Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Warner

Showing results (541-550 of 594) with videos related to

Pageof 60
Sort By:
Clinical Lung Cancer|June 5, 2014
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancerAllison B Ashworth, Suresh Senan, David A Palma, et al.
Plant Disease|February 16, 2022
Reduction of Pythium Damping-Off in Soybean by Biocontrol Seed TreatmentMirian F Pimentel, Erika Arnao, Amanda J Warner, et al.
Journal of Medical Genetics|March 16, 2007
Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational studyOliver W J Quarrell, Alan S Rigby, L Barron, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
The Journal of Bone and Joint Surgery. American Volume|January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic ProphylaxisCarol A Lin, Nathan N O'Hara, Sheila Sprague, et al.
Journal of the American Academy of Dermatology|September 27, 2000
A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patternsM A Ghannoum, R A Hajjeh, R Scher, et al.
The Lancet. Oncology|June 22, 2014
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trialBradley J Monk, Andrés Poveda, Ignace Vergote, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinasesJ G Conway, R C Andrews, B Beaudet, et al.
Injury|June 19, 2024
Outcomes of isolated medial tibial plateau fractures by fracture morphologyJacquelyn P Cruz, Jack B Michaud, Noelle L Van Rysselberghe, et al.
Injury|October 23, 2024
Do the results of the OXYGEN trial change if analyzed as "as-treated?": A secondary analysis of the OXYGEN trialAugustine M Saiz, Anthony R Carlini, Renan C Castillo, et al.
Pageof 60

Showing results (541-550 of 594) with videos related to

Sort By:
Pageof 60
Clinical Lung Cancer|June 5, 2014
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancerAllison B Ashworth, Suresh Senan, David A Palma, et al.
Plant Disease|February 16, 2022
Reduction of Pythium Damping-Off in Soybean by Biocontrol Seed TreatmentMirian F Pimentel, Erika Arnao, Amanda J Warner, et al.
Journal of Medical Genetics|March 16, 2007
Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational studyOliver W J Quarrell, Alan S Rigby, L Barron, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
The Journal of Bone and Joint Surgery. American Volume|January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic ProphylaxisCarol A Lin, Nathan N O'Hara, Sheila Sprague, et al.
Journal of the American Academy of Dermatology|September 27, 2000
A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patternsM A Ghannoum, R A Hajjeh, R Scher, et al.
The Lancet. Oncology|June 22, 2014
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trialBradley J Monk, Andrés Poveda, Ignace Vergote, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinasesJ G Conway, R C Andrews, B Beaudet, et al.
Injury|June 19, 2024
Outcomes of isolated medial tibial plateau fractures by fracture morphologyJacquelyn P Cruz, Jack B Michaud, Noelle L Van Rysselberghe, et al.
Injury|October 23, 2024
Do the results of the OXYGEN trial change if analyzed as "as-treated?": A secondary analysis of the OXYGEN trialAugustine M Saiz, Anthony R Carlini, Renan C Castillo, et al.
Pageof 60